OREANDA-NEWS. April 14, 2010. JSC “Grindeks” has received the notification on obtaining significant holding from OJSC “Pharmstandart”. “Pharmstandart's” total holdings in the security of JSC “Grindeks” currently amount to 11.3% of the outstanding shares.

“Grindeks” Chairman of the Board Janis Romanovskis: “OJSC “Pharmstandart” is the leading Russian pharmaceutical company and since 2008 is one of the most important cooperation partners of “Grindeks” that promotes and sells our brand product Mildrontate®. OJSC “Pharmstandart” as one of the biggest shareholders of “Grindeks” will strengthen our positions in Russia and provide new business opportunities.”